A detailed history of Hsbc Holdings PLC transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 19,534 shares of NAUT stock, worth $44,928. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,534
Previous 17,468 11.83%
Holding current value
$44,928
Previous $40,000 37.5%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.24 - $3.08 $4,627 - $6,363
2,066 Added 11.83%
19,534 $55,000
Q2 2024

Aug 12, 2024

SELL
$2.22 - $3.0 $17,906 - $24,198
-8,066 Reduced 31.59%
17,468 $40,000
Q1 2024

May 15, 2024

BUY
$2.41 - $3.18 $17,038 - $22,482
7,070 Added 38.29%
25,534 $75,000
Q4 2021

Feb 11, 2022

BUY
$4.45 - $6.21 $82,164 - $114,661
18,464 New
18,464 $95,000

Others Institutions Holding NAUT

About Nautilus Biotechnology, Inc.


  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $287M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.